Safety of high-dose tirofiban in patient undergoing coronary angioplasty

Trial Profile

Safety of high-dose tirofiban in patient undergoing coronary angioplasty

Completed
Phase of Trial: Phase IV

Latest Information Update: 01 Feb 2011

At a glance

  • Drugs Tirofiban (Primary) ; Clopidogrel
  • Indications Coronary artery disease; Embolism and thrombosis
  • Focus Adverse reactions
  • Acronyms SANTISS
  • Most Recent Events

    • 01 Feb 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 14 Jul 2008 Status changed from initiated to recruiting as reported by ClinicalTrials.gov.
    • 11 Dec 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top